5-MeO-MET Stats & Data
PubChem
MW232.32
FormulaC14H20N2O
LogP1.9
IUPACN-ethyl-2-(5-methoxy-1H-indol-3-yl)-N-methylethanamine
InChIKey
AVECDEWGCOLCPZ-UHFFFAOYSA-N
Chemical Class
Substituted tryptamine
Psychoactive Class
Psychedelic
Effect Profile
Curated + 1 Reports
Psychedelic
2.8
Moderate body load with mild visuals, low headspace
Visual Intensity×3
4
Headspace Depth×3
2
Auditory Effects×1
0
Body Load / Somatic Effects×1
6
Duration Timeline
Bluelight
Onset
Comeup
Peak
Offset
After Effects
Oral
Smoked
Community Effects
TripSit
Negative
body load
Tolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Full tolerance
1h
Half tolerance
10d
Baseline
~14d
Cross-Tolerances
LSD
Psilocybin
Psilocin
Mescaline
DMT
5-MeO-DMT
2C-B
2C-E
Experience Report Analysis
Erowid
3
Reports
1
Single-substance
2020–2022
Date Range
3
With Age Data
Demographics
Gender Distribution
Too few reports for a chart: gender is known from 3 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?
- Male 2 of 3
- Not Specified 1 of 3
Age Distribution
Reports Over Time
Real-World Dose Distribution
62K DosesFrom 12 individual dose entries. Values above Q3 + 3×IQR are left out as outliers.
Oral (n=9)
Median: 25.0mg
25th: 16.0mg
75th: 49.0mg
90th: 49.0mg